Company mentioned on podcasts
Blueprint Medicines
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
- Kate HavilandAuthor
“Kate Haviland, former CEO of Blueprint Medicines, traces the company's evolution from a precision oncology startup to a precision immunology leader, culminating in Sanofi's $9.1 billion acquisition in 2025.”
Mentioned on: The Long Run with Luke Timmerman